{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:38:14Z","timestamp":1790800694098,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019158","name":"Fundaci\u00f3n Espa\u00f1ola de Reumatolog\u00eda","doi-asserted-by":"publisher","award":["FERBT2022"],"award-info":[{"award-number":["FERBT2022"]}],"id":[{"id":"10.13039\/501100019158","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.autrev.2023.103413","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:34:37Z","timestamp":1692416077000},"page":"103413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Performance of the new 2022 ACR\/EULAR classification criteria for giant cell arteritis in clinical practice in relation to its clinical phenotypes"],"prefix":"10.1016","volume":"22","author":[{"given":"Javier","family":"Narv\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vidal-Montal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Miquel","family":"Nolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103413_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221096366","article-title":"Looking ahead: giant-cell arteritis in 10 years\u2019 time","volume":"14","author":"Bond","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"Suppl. 124","key":"10.1016\/j.autrev.2023.103413_bb0010","first-page":"15","article-title":"Giant cell arteritis: more than a cranial disease","volume":"38","author":"Gonz\u00e1lez-Gay","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103413_bb0015","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103413_bb0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0049-0172(95)80010-7","article-title":"Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation","volume":"24","author":"Lie","year":"1995","journal-title":"Semin Arthritis Rheum"},{"issue":"suppl_2","key":"10.1016\/j.autrev.2023.103413_bb0025","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1093\/rheumatology\/kex424","article-title":"Large-vessel giant cell arteritis: diagnosis, monitoring and management","volume":"57","author":"Koster","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103413_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105558","article-title":"Clinical phenotype and complications of large vessel giant cell arteritis: a systematic review and meta-analysis","volume":"90","author":"Lyne","year":"2023","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2023.103413_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica. A systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103413_bb0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.semarthrit.2015.06.009","article-title":"Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica","volume":"45","author":"Narv\u00e1ez","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103413_bb0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103413_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103413_bb0055","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2023.103413_bb0060","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103413_bb0065","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103413_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002970","article-title":"Performance of the 2022 ACR\/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care","volume":"9","author":"Molina-Collada","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2023.103413_bb0075","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC","volume":"45","author":"Slart","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.autrev.2023.103413_bb0080","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103413_bb0085","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211009029","article-title":"Large-vessel involvement is predictive of multiple relapses in giant cell arteritis","volume":"13","author":"de Mornac","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.autrev.2023.103413_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-020-02171-6","article-title":"Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions","volume":"22","author":"Sugihara","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103413_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13075-020-02396-5","article-title":"Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event","volume":"23","author":"Espitia","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103413_bb0100","series-title":"Presented at: 2018 ACR\/AHP annual meeting","article-title":"ACR: Updated classification criteria for large-vessel vasculitis","author":"Merkel","year":"2018"},{"key":"10.1016\/j.autrev.2023.103413_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead161","article-title":"Validation of the 2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis","author":"Tomelleri","year":"2023","journal-title":"Rheumatology (Oxford)"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:39Z","timestamp":1761600459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1568997223001477"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103413","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of the new 2022 ACR\/EULAR classification criteria for giant cell arteritis in clinical practice in relation to its clinical phenotypes","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103413"}}